Covid-19 roundup: CDER ponders a move to virtual adcomms; conservative group urges easier access to hydroxychloroquine
It’s all hands on the virtual deck at the FDA. And the folks at CDER are considering setting up a new online approach to holding …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
